Loading...
Troikaa Pharmaceuticals Limited — Sodium Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #9 for Sodium · $10.2M export value · DGFT Verified
Troikaa Pharmaceuticals Limited is the #9 Indian exporter of Sodium with $10.2M in export value and 235 verified shipments. Troikaa Pharmaceuticals Limited holds a 2.8% market share in Sodium exports across 27 countries. The company exports 13 pharmaceutical products worth $40.4M across 6 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| FRANCE | $12.7M | 329 | 56.3% |
| UGANDA | $2.7M | 78 | 11.9% |
| SUDAN | $1.1M | 39 | 4.8% |
| PHILIPPINES | $1.1M | 35 | 4.8% |
| THAILAND | $906.8K | 26 | 4.0% |
| MYANMAR | $608.6K | 22 | 2.7% |
| UZBEKISTAN | $428.0K | 12 | 1.9% |
| JAMAICA | $404.5K | 10 | 1.8% |
| KYRGHYSTAN | $333.6K | 21 | 1.5% |
| DOMINICAN REPULIC | $244.0K | 8 | 1.1% |
Troikaa Pharmaceuticals Limited exports Sodium to 58 countries. The largest destination is FRANCE accounting for 56.3% of Troikaa Pharmaceuticals Limited's Sodium shipments, followed by UGANDA (11.9%) and SUDAN (4.8%). These destinations reflect Troikaa Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| PLANET PHARMA | FRANCE | $8.8M | 234 |
| P.P | FRANCE | $1.2M | 32 |
| PLANETPHARMA | FRANCE | $1.0M | 24 |
| P . P | FRANCE | $984.8K | 22 |
| ALWALI MEDICAL ENTERPRISES | SUDAN | $793.9K | 30 |
| LLC SERENE PHARMA | UZBEKISTAN | $690.4K | 31 |
India exported $145.4M worth of Sodium through 15,000 shipments from 985 suppliers to 177 countries, serving 2,469 buyers globally. Troikaa Pharmaceuticals Limited contributes $10.2M to this total, accounting for 2.8% of India's Sodium exports. Troikaa Pharmaceuticals Limited ships Sodium to 58 countries through 146 buyers.
Troikaa Pharmaceuticals Limited's average Sodium shipment value is $43.5K per consignment, based on 235 shipments totaling $10.2M. The largest destination is FRANCE (56.3% of Troikaa Pharmaceuticals Limited's Sodium exports).
Troikaa Pharmaceuticals Limited ranks #9 among 985 Indian Sodium exporters with a 2.8% market share. The top 3 exporters are CIPLA LIMITED ($22.2M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($15.4M), EUGIA PHARMA SPECIALITIES LIMITED ($13.6M). Troikaa Pharmaceuticals Limited processed 235 shipments to 27 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| DYNAPAR DICLOFENAC SODIUM AND PARACETAMO | $1.3M | 32 |
| RESTRIVA INJECTION 5ML METAMIZOLE SODIUM | $1.0M | 22 |
| TROYPANTO PANTOPRAZOLE SODIUM DELAYED-RE | $522.5K | 16 |
| DYNAPAR AQ 1ML DICLOFENAC SODIUM INJECTI | $488.1K | 25 |
| RESTRIVA TABLETS METAMIZOLE SODIUM TABLE | $441.5K | 11 |
| DYNAPAR AQ DICLOFENAC SODIUM INJECTION 7 | $412.2K | 12 |
| PHARMACEUTICALS FORMULATIONS -DYNAPAR DICLOFENAC SODIUM AND PARACETAMOL TABLETS | $404.8K | 14 |
| RESTRIVA INJECTION 5ML METAMIZOLE SODIUMINJECTION 500 mg ml OTHER DETAILS AS PER INV PL | $341.7K | 7 |
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | GLAND PHARMA LIMITED | $11.4M | 229 | 21 | $50.0K |
| 6 | UNICHEM LABORATORIES LIMITED | $10.9M | 219 | 2 | $50.0K |
| 9 | TROIKAA PHARMACEUTICALS LIMITED ★ | $10.2M | 235 | 27 | $43.5K |
| 12 | TORRENT PHARMACEUTICALS LTD | $8.5M | 248 | 22 |
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 2,869 | 19.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 1,813 | 12.1% |
| DELHI AIR CARGO ACC (INDEL4) | 1,734 | 11.6% |
| JNPT | 844 | 5.6% |
| HYDERABAD ICD (INSNF6) | 804 | 5.4% |
| Bombay Air | 617 | 4.1% |
| AHEMDABAD ICD (INSBI6) | 445 | 3.0% |
| Delhi Air | 431 | 2.9% |
Troikaa Pharmaceuticals Limited also exports these nutritional supplements products. Each links to the detailed product page.
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Troikaa. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight costs and extended transit times. These logistical challenges are particularly impactful for time-sensitive pharmaceutical shipments, potentially affecting Troikaa's supply chain efficiency. (pharmaceuticalcommerce.com)
In the United States, recent tariff implementations have introduced uncertainties for Indian exporters. While initial tariffs targeted various sectors, the pharmaceutical industry has faced threats of increased duties, prompting companies to reassess their export strategies. (apnews.com) Conversely, the India–EFTA Trade and Economic Partnership Agreement, effective from October 2025, aims to reduce tariffs and promote trade between India and EFTA countries, potentially opening new avenues for Troikaa in European markets. (en.wikipedia.org)
Compliance with international regulatory standards remains a critical factor for Indian pharmaceutical exporters. The U.S. FDA has intensified inspections, with over 200 conducted in 2023 and plans to increase this number in 2024. (fact.net.in) This heightened scrutiny underscores the necessity for companies like Troikaa to maintain stringent quality control measures to ensure uninterrupted market access.
Additionally, the European Union's Falsified Medicines Directive imposes rigorous requirements on pharmaceutical imports, necessitating robust traceability and authentication systems. Adherence to these evolving regulations is imperative for sustaining Troikaa's export operations in these regions.
Troikaa Pharmaceuticals Limited exports 13 products worth $40.4M. Beyond Sodium, top products include Diclofenac, Heparin, Enoxaparin, Amiodarone, Nitroglycerin. View the complete Troikaa Pharmaceuticals Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Sodium — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Troikaa Pharmaceuticals Limited's Sodium exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Troikaa Pharmaceuticals Limited
Full Company Profile →
13 products · $40.4M total trade · 6 categories
| ABACUS PHARMA A LIMITED |
| UGANDA |
| $612.9K |
| 16 |
| ABACUS PHARMA (A) LTD. | UGANDA | $525.3K | 17 |
| TROIKAA PHARMACEUTICALS PHILIPPINES | PHILIPPINES | $467.3K | 18 |
| PLANETPHARMA ZAC DU GRAND LAUNAY | FRANCE | $410.5K | 10 |
Troikaa Pharmaceuticals Limited supplies Sodium to 146 buyers globally. The largest buyer is PLANET PHARMA (FRANCE), followed by P.P (FRANCE) and PLANETPHARMA (FRANCE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
| TROYNOXA 40 ENOXAPARIN SODIUM INJECTION |
| $314.7K |
| 9 |
| PHARMACEUTICALS FORMULATIONS DYNAPAR DICLOFENAC SODIUM AND PARACETAMOL TABLETS SHELF LIFE: 48 MONTH 10X10 TABNOS | $303.8K | 8 |
Troikaa Pharmaceuticals Limited exports 472 distinct Sodium formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DYNAPAR DICLOFENAC SODIUM AND PARACETAMO with 32 shipments worth $1.3M. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
| $34.3K |
| 14 | FRESENIUS KABI INDIA PRIVATE LIMITED | $7.8M | 332 | 17 | $23.4K |
Troikaa Pharmaceuticals Limited ranks #9 among 985 Indian Sodium exporters. Average shipment value of $43.5K compared to the market average of $147.6K. The closest competitors by value are GLAND PHARMA LIMITED and UNICHEM LABORATORIES LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 177+ countries, 2,469+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Troikaa Pharmaceuticals Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Sodium. For current shipment-level data, contact TransData Nexus.